thiomethisosildenafil: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 56841591 |
| SCHEMBL ID | 5450729 |
| MeSH ID | M0534219 |
| Synonym |
|---|
| 33dx49e09g , |
| unii-33dx49e09g |
| thioaildenafil |
| sulfoaildenafil |
| sildenafil thione |
| 7h-pyrazolo(4,3-d)pyrimidine-7-thione, 5-(5-(((3r,5s)-3,5-dimethyl-1-piperazinyl)sulfonyl)-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-, rel- |
| thiomethisosildenafil |
| 856190-47-1 |
| dimethylthiosildenafil |
| 1260112-90-0 |
| piperazine, 1-((3-(4,7-dihydro-1-methyl-3-propyl-7-thioxo-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-3,5-dimethyl-, (3r,5s)-rel- |
| j2.743.777j , |
| dimethylsildenafil thione |
| DTXSID20234860 |
| SCHEMBL5450729 |
| 5-[2-ethoxy-5-(cis-3,5-dimethylpiperazine-1-sulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7h-pyrazolo[4,3-d]pyrimidin-7-thione |
| SCLUKEPFXXPARW-GASCZTMLSA-N |
| Q7636205 |
| 5-[5-[(3s,5r)-3,5-dimethylpiperazin-1-yl]sulfonyl-2-ethoxyphenyl]-1-methyl-3-propyl-4h-pyrazolo[4,3-d]pyrimidine-7-thione |
| E87139 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ten herbal dietary supplements, each as a capsule dosage form, were found to contain 8-151 mg of thiomethisosildenafil per capsule, and one herbal dietary supplement was found to contain 35 mg of thiosildenafil per capsule." | ( Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs. d'Avignon, DA; Reepmeyer, JC, 2009) | 0.57 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.75) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||